Drugs in resuscitation: an update

Area of Science:

• Emergency Medicine
• Cardiology
• Clinical Pharmacology

Background:

• Drug therapy is a recommended intervention following cardiopulmonary resuscitation and defibrillation in cardiac arrest.
• Certain medications, including vasopressors and antiarrhythmics, demonstrate short-term survival benefits, leading to their inclusion in cardiac life support algorithms.

Purpose of the Study:

• To provide an updated review of drug usage during resuscitation.
• To discuss agent selection, dosage, sequence, and administration routes for medications used in cardiac arrest.
• To explore the potential benefits of specific drugs in addressing underlying causes of cardiac arrest.

Main Methods:

• Literature review of recent studies on drug therapy in cardiac arrest resuscitation.
• Analysis of current cardiac life support guidelines regarding medication use.
• Examination of evidence for short-term and long-term survival benefits of various drugs.

Main Results:

• Current drug protocols primarily focus on improving survival to hospital admission.
• No drug or combination has demonstrated a significant improvement in long-term survival in randomized controlled trials.
• Specific drugs may be beneficial for treating identified causes of cardiac arrest.

Conclusions:

• Drug therapy in cardiac arrest resuscitation is an evolving field.
• While short-term survival may be enhanced, long-term outcomes remain a challenge.
• Improvements in post-arrest intensive care are crucial for translating in-hospital survival into better long-term patient outcomes.